$8.98
0.435.03%
At Close: -
$9.08
0.11.11%
After Hours: Sep 20, 7:14 PM EDT
15 minutes delayed
Enfusion reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Enfusion using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $0.05 | $0.06 | -16.7 % |
Mar 2024 | 2024-05-09 | $0.06 | $0.04 | 50.0 % |
Dec 2023 | 2024-03-12 | $0.04 | $0.05 | -20.0 % |
Sep 2023 | 2023-11-07 | $0.02 | $0.05 | -60.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $49.46M | $50.05M | -1.19 % |
Mar 2024 | 2024-05-09 | $48.05M | $47.61M | 0.93 % |
Dec 2023 | 2024-03-12 | $46.49M | $45.27M | 2.69 % |
Sep 2023 | 2023-11-07 | $44.36M | $44.05M | 0.70 % |
Enfusion (ENFN) is scheduled to report earnings on November 5, 2024. The last reported earnings were for reported on August 6, 2024 for Q2.
The Actual EPS was $0.05, which missed the estimate of $0.06.
The Actual Revenue was $49.5M, which missed the estimate of $50M.
Browse earnings estimates, EPS, and revenue on all stocks.